指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

儿童疑似或确诊2019冠状病毒病重症监护:欧洲儿科与新生儿重症监护学会科学分会协作组建议

Caring for Critically Ill Children With Suspected or Proven Coronavirus Disease 2019 Infection: Recommendations by the Scientific Sections' Collaborative of the European Society of Pediatric and Neonatal Intensive Care.
指南 / 共识 · Pediatr Crit Care Med · 2021-01-01
一句话结论儿童COVID-19多为轻症,但可发生严重低氧性呼吸衰竭或严重多系统炎症综合征(后者为感染后综合征,可伴心脏受累或中毒性休克样表现);本建议基于有限经验与专家意见,缺乏儿童对照试验。

该临床指导文章由欧洲儿科与新生儿重症监护学会(ESPNIC)科学分会协作组制定,检索PubMed与开放网络至2020年7月10日。文章指出儿童COVID-19临床研究极少,除描述性数据和流行病学外证据有限;基本治疗和器官支持与其他儿童重症(如脓毒性休克、多器官衰竭)似乎差别不大,但需考虑若干特殊问题。文章主要基于有限经验的专家意见,缺乏儿童完成的对照试验。

要点

  • 儿童COVID-19通常为轻症,但可发展为严重低氧性呼吸衰竭或严重多系统炎症综合征。
  • 严重多系统炎症综合征被认为是感染后综合征,可单独心脏受累或伴中毒性休克样表现。
  • 基本治疗和器官支持考虑似乎与PICU其他重症(如儿童脓毒性休克、多器官衰竭)差别不大。
  • 文章讨论了一些基于有限经验专家意见的特殊治疗概念,强调缺乏儿童完成的对照试验。

适用人群与场景

  • 疑似或确诊2019冠状病毒病感染的危重儿童。

红旗征与不能漏的情况

  • 严重低氧性呼吸衰竭。
  • 严重多系统炎症综合征,可伴心脏受累或中毒性休克样表现。

研究设计与关键结果

  • 文章为临床指导文章,由欧洲儿科与新生儿重症监护学会科学分会协作组制定,检索PubMed与开放网络至2020年7月10日。
  • 儿童COVID-19临床研究极少,除描述性数据和流行病学外证据有限。
  • 基本治疗和器官支持考虑似乎与PICU其他重症(如儿童脓毒性休克、多器官衰竭)差别不大,但需考虑一些特殊问题。
  • 讨论的特殊治疗概念主要基于有限经验的专家意见,缺乏儿童完成的对照试验。

证据类型、等级与局限

  • 证据类型:临床指导文章(专家意见),基于有限经验。
  • 局限:缺乏儿童完成的对照试验;儿童COVID-19临床研究极少,除描述性数据和流行病学外证据有限。

对床旁实践的改变

  • 对于危重儿童COVID-19,基本治疗和器官支持可参考PICU其他重症(如儿童脓毒性休克、多器官衰竭)的考虑,但需注意一些特殊问题。
  • 作者基于有限经验的专家意见讨论了一些特殊治疗概念,强调缺乏儿童完成的对照试验。
  • 原文未据此给出具体推荐。

指南或共识出处

  • 欧洲儿科与新生儿重症监护学会(European Society of Pediatric and Neonatal Intensive Care)科学分会协作组临床指导文章,发表于Pediatric Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: In children, coronavirus disease 2019 is usually mild but can develop severe hypoxemic failure or a severe multisystem inflammatory syndrome, the latter considered to be a postinfectious syndrome, with cardiac involvement alone or together with a toxic shock like-presentation. Given the novelty of severe acute respiratory syndrome coronavirus 2, the causative agent of the recent coronavirus disease 2019 pandemic, little is known about the pathophysiology and phenotypic expressions of this new infectious disease nor the optimal treatment approach.

STUDY SELECTION: From inception to July 10, 2020, repeated PubMed and open Web searches have been done by the scientific section collaborative group members of the European Society of Pediatric and Neonatal Intensive Care.

DATA EXTRACTION: There is little in the way of clinical research in children affected by coronavirus disease 2019, apart from descriptive data and epidemiology.

DATA SYNTHESIS: Even though basic treatment and organ support considerations seem not to differ much from other critical illness, such as pediatric septic shock and multiple organ failure, seen in PICUs, some specific issues must be considered when caring for children with severe coronavirus disease 2019 disease.

CONCLUSIONS: In this clinical guidance article, we review the current clinical knowledge of coronavirus disease 2019 disease in critically ill children and discuss some specific treatment concepts based mainly on expert opinion based on limited experience and the lack of any completed controlled trials in children at this time.

来源:Pediatr Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Rimensberger PC, Kneyber MCJ, Deep A, et al. Caring for Critically Ill Children With Suspected or Proven Coronavirus Disease 2019 Infection: Recommendations by the Scientific Sections' Collaborative of the European Society of Pediatric and Neonatal Intensive Care. Pediatr Crit Care Med. 2021. PMID: 33003177. doi:10.1097/PCC.0000000000002599

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。